{"protocolSection":{"identificationModule":{"nctId":"NCT06481332","orgStudyIdInfo":{"id":"29BRC24.0135 - CASTETTE"},"organization":{"fullName":"University Hospital, Brest","class":"OTHER"},"briefTitle":"Diagnostic Characterization and Evolution of \"Triple Negative\" Thrombocytosis (CASTETTE)","officialTitle":"Diagnostic Characterization and Evolution of \"Triple Negative\" Thrombocytosis","acronym":"CASTETTE"},"statusModule":{"statusVerifiedDate":"2024-04","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06-25","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-25","studyFirstSubmitQcDate":"2024-06-25","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-25","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital, Brest","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Evaluation of Event free survival in patients with triple-negative thrombocytosis","detailedDescription":"Patients with non-reactive thrombocytosis, explored at least by bone marrow biopsy and NGS panel will be included. Clinical and biological characteristics as well as evolution will be recorded retrospectively."},"conditionsModule":{"conditions":["Myeloproliferative Neoplasm"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Event-free survival","timeFrame":"3 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with non reactive thrombocytosis for at least 6 months\n* availability of bone marrow biopsy and NGS panel\n\nExclusion Criteria:\n\n* Unable to consent","sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients followed by hematologists of the French Intergroup of MPN","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"Chu Brest","city":"Brest","zip":"29609","country":"France","geoPoint":{"lat":48.3903,"lon":-4.48628}}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"All collected data that underlie results in a publication","infoTypes":["STUDY_PROTOCOL"],"timeFrame":"Data will be available beginning three years and ending fifteen years following the final study report completion","accessCriteria":"Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000009196","term":"Myeloproliferative Disorders"},{"id":"D000013922","term":"Thrombocytosis"}],"ancestors":[{"id":"D000001855","term":"Bone Marrow Diseases"},{"id":"D000006402","term":"Hematologic Diseases"},{"id":"D000001791","term":"Blood Platelet Disorders"}],"browseLeaves":[{"id":"M12149","name":"Myeloproliferative Disorders","asFound":"Myeloproliferative Neoplasms","relevance":"HIGH"},{"id":"M16681","name":"Thrombocytosis","asFound":"Thrombocytosis","relevance":"HIGH"},{"id":"M5134","name":"Bone Marrow Diseases","relevance":"LOW"},{"id":"M9490","name":"Hematologic Diseases","relevance":"LOW"},{"id":"M5072","name":"Blood Platelet Disorders","relevance":"LOW"},{"id":"T1311","name":"Chronic Myeloproliferative Disorders","asFound":"Myeloproliferative Neoplasms","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC15","name":"Blood and Lymph Conditions"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}